Efficacy and Safety of Itolizumab in COVID-19 Complications

Clinical trial NCT04475588 · COMPLETED

Trial details

NCT number: NCT04475588
Sponsor: Biocon Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome Cytokine Release Syndrome Covid19

Start date: 2020-05-01
Primary completion: 2020-07-07
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.